The Journal of Gene Medicine

2.1k papers and 54.5k indexed citations i.

About

The 2.1k papers published in The Journal of Gene Medicine in the last decades have received a total of 54.5k indexed citations. Papers published in The Journal of Gene Medicine usually cover Molecular Biology (1.5k papers), Genetics (1.0k papers) and Oncology (318 papers) specifically the topics of Virus-based gene therapy research (933 papers), RNA Interference and Gene Delivery (716 papers) and CRISPR and Genetic Engineering (228 papers). The most active scholars publishing in The Journal of Gene Medicine are Daniel Scherman, Ernst Wagner, Olivier Danos, Seppo Ylä‐Herttuala and Keiya Ozawa.

In The Last Decade

Fields of papers published in The Journal of Gene Medicine

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in The Journal of Gene Medicine. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in The Journal of Gene Medicine

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in The Journal of Gene Medicine. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in The Journal of Gene Medicine with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025